Synthesis and in vitro drug release studies on substituted polyphosphazene conjugates of lumefantrine.

  • Kumar S
  • Sharma A
  • Singh R
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The present study pertains to the delivery of antimalarial drug (Lumifantrine). In this, polyphosphazene has been used in the synthesis of polyphosphazene-linked conjugates of Lumifantrine. These polymer-linked Conjugates have been synthesized and characterized by modern analytical techniques. The in-vitro drug release of Lumifantrine drug conjugates: p -Amino benzoic acid ester substituted polyphosphazene drug conjugate (15) and Glycine methyl ester substituted polyphosphazene drug conjugate (21) have been found to be 6.00 % and 5.96% (pH 1.2), 88.52% and 79.86% (pH 7.4), respectively. These drug conjugate may prove an effective delivery system for the treatment of malaria.

Cite

CITATION STYLE

APA

Kumar, S., Sharma, A., Singh, R. K., Prasad, D., & Bhardwaj, T. (2017). Synthesis and in vitro drug release studies on substituted polyphosphazene conjugates of lumefantrine. International Journal of Drug Delivery, 9(2), 36. https://doi.org/10.5138/09750215.2133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free